Early Detection of Cancer
"Early Detection of Cancer" is a descriptor in the National Library of Medicine's controlled vocabulary thesaurus,
MeSH (Medical Subject Headings). Descriptors are arranged in a hierarchical structure,
which enables searching at various levels of specificity.
Methods to identify and characterize cancer in the early stages of disease and predict tumor behavior.
| Descriptor ID |
D055088
|
| MeSH Number(s) |
E01.390.500
|
| Concept/Terms |
Cancer Screening Tests- Cancer Screening Tests
- Cancer Screening Test
- Screening Test, Cancer
- Screening Tests, Cancer
- Test, Cancer Screening
- Tests, Cancer Screening
|
Below are MeSH descriptors whose meaning is more general than "Early Detection of Cancer".
Below are MeSH descriptors whose meaning is more specific than "Early Detection of Cancer".
This graph shows the total number of publications written about "Early Detection of Cancer" by people in this website by year, and whether "Early Detection of Cancer" was a major or minor topic of these publications.
To see the data from this visualization as text,
click here.
| Year | Major Topic | Minor Topic | Total |
|---|
| 2008 | 0 | 2 | 2 |
| 2009 | 0 | 2 | 2 |
| 2010 | 4 | 3 | 7 |
| 2011 | 5 | 5 | 10 |
| 2012 | 9 | 4 | 13 |
| 2013 | 6 | 6 | 12 |
| 2014 | 19 | 6 | 25 |
| 2015 | 14 | 12 | 26 |
| 2016 | 11 | 11 | 22 |
| 2017 | 15 | 12 | 27 |
| 2018 | 17 | 13 | 30 |
| 2019 | 11 | 11 | 22 |
| 2020 | 12 | 13 | 25 |
| 2021 | 11 | 17 | 28 |
| 2022 | 5 | 19 | 24 |
| 2023 | 5 | 21 | 26 |
| 2024 | 12 | 5 | 17 |
To return to the timeline,
click here.
Below are the most recent publications written about "Early Detection of Cancer" by people in Profiles.
-
Update on Recommendations for Cancer Screening and Surveillance in Children with Genomic Instability Disorders. Clin Cancer Res. 2024 Nov 15; 30(22):5009-5020.
-
Harmonizing data across the accelerating colorectal cancer screening and follow-up through implementation science (ACCSIS) program to enhance data quality and promote data sharing. BMC Health Serv Res. 2024 Nov 06; 24(1):1356.
-
Updates in Breast Cancer Screening and Diagnosis. Curr Treat Options Oncol. 2024 Nov; 25(11):1451-1460.
-
5-Hydroxymethylated Biomarkers in Cell-Free DNA Predict Occult Colorectal Cancer up to 36 Months Before Diagnosis in the Prostate, Lung, Colorectal, and Ovarian Cancer Screening Trial. JCO Precis Oncol. 2024 Oct; 8:e2400277.
-
Characteristics of a cost-effective blood test for colorectal cancer screening. J Natl Cancer Inst. 2024 Oct 01; 116(10):1612-1620.
-
Breast Cancer Screening Interval: Effect on Rate of Late-Stage Disease at Diagnosis and Overall Survival. J Clin Oncol. 2024 Nov 10; 42(32):3837-3846.
-
Association Between Clinician Confidence and Making Guideline-Recommended Decisions in the Management of Abnormal Cervical Cancer Screening Results. J Gen Intern Med. 2024 Dec; 39(16):3217-3224.
-
Out-of-pocket costs for diagnostic testing following abnormal prostate cancer screening among privately insured men. Cancer. 2024 Oct 01; 130(19):3305-3310.
-
Assessing Management of Abnormal Cervical Cancer Screening Results and Concordance with Guideline Recommendations in Three US Healthcare Settings. Cancer Epidemiol Biomarkers Prev. 2024 Jul 01; 33(7):912-922.
-
Closing the Cervical Cancer Screening Gap-Reaching Sexual and Gender Diverse Populations. JAMA Netw Open. 2024 May 01; 7(5):e248855.